0001209191-20-035116.txt : 20200608
0001209191-20-035116.hdr.sgml : 20200608
20200608190539
ACCESSION NUMBER: 0001209191-20-035116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191221
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oliveto Joseph
CENTRAL INDEX KEY: 0001437782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38899
FILM NUMBER: 20950481
MAIL ADDRESS:
STREET 1: C/O CHELSEA THERAPEUTICS, INC.
STREET 2: 3530 TORINGDON WAY, SUITE 200
CITY: CHARLOTTE
STATE: NC
ZIP: 28277
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001408443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
BUSINESS PHONE: (514) 336-0444
MAIL ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-21
0
0001408443
Milestone Pharmaceuticals Inc.
MIST
0001437782
Oliveto Joseph
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTR?AL
A8
H4M 2X6
QUEBEC, CANADA
1
1
0
0
President and CEO
Common Shares
2019-12-21
4
M
0
7400
1.54
A
280555
D
Employee Stock Option (right to buy)
1.54
2019-12-21
4
M
0
7400
0.00
D
2027-12-12
Common Shares
7400
113856
D
Employee Stock Option (right to buy)
3.74
2020-06-05
4
A
0
150000
0.00
A
2030-06-05
Common Shares
150000
150000
D
The original grant was for 252,853 option shares. Twenty-five percent (25%) of the shares subject to the option vested on September 19, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
The shares subject to this option shall vest in twenty-four (24) equal monthly installments commencing on July 5, 2020, subject to the recipient continuing to provide service to the Issuer through each such date.
/s/ Eric Popp, Attorney-in-Fact
2020-06-08